The drug is made in the form of a solution for injection
–
–
The tool will be used to treat coronavirus in adults and adolescents from 12 to 17 years old.
China has approved the country’s first combination therapy for COVID, which is made on the basis of neutralizing antibodies. About it informs Press Service of the State Administration for the Control of Pharmaceutical Products of the PRC.
The tool will be used to treat adults and adolescents from 12 to 17 years old against coronavirus.
The registration of the drug, which is made in the form of a solution for injection, has been filed by the Beijing company Tengsheng Huachuang Pharmaceutical Technology.
It is noted to be the first Chinese-approved combination therapy with independent intellectual property rights.
Earlier it was reported that Britain approved COVID drug potentially effective against Omicron.
EU first approves coronavirus drug
News from Correspondent.net in Telegram. Subscribe to our channel https://t.me/korrespondentnet
– .
